Effects of fibronectin/integrin β signaling on short-term high fat diet induced hepatic steatosis and the underlying mechanism

内科学 脂肪生成 内分泌学 脂肪变性 纤维连接蛋白 过氧化物酶体增殖物激活受体 脂肪肝 生物 FNDC5 脂质代谢 受体 化学 生物化学 医学 细胞外基质 疾病
作者
Feifei Zhang,Xuejiao Zhang,Chunjiong Wang,Yao Liu,Xiao Ma,Wenli Liu,Jing Huang,Ding Ai
出处
期刊:Chinese Journal of Endocrinology and Metabolism [Chinese Medical Association]
卷期号:32 (9): 773-780
标识
DOI:10.3760/cma.j.issn.1000-6699.2016.09.013
摘要

Objective To investigate the effects of fibronectin/ integrin β signaling on short-term high fat diet induced hepatic steatosis and the underlying mechanism. Methods Male C57BL/6 mice were treated with high fat diet or high fat diet combined with ATN161, an inhibitor of integrin β. Serum biochemical parameters and liver histological examinations were observed. The expression of lipid metabolic genes in mice liver were detected with realtime PCR and the protein levels of peroxisome proliferator-activated receptor γ(PPAR γ)and stearic acyl coenzyme A desaturase 1(SCD1)were determined with Western blot. Results (1)High fat diet increased hepatic lipid accumulation and the expressions of fibronectin and α-smooth muscle actin(α-SMA). (2)ATN161 down-regulated the expression of α-SMA while increased hepatic lipid accumulation and the expression of genes involved in lipogenesis and lipid uptake in high fat diet fed mice. The up-regulated genes were target genes of PPAR γ, which was also up-regulated. The protein levels of PPAR γ and SCD1 were also increased. (3)The inhibiting effects of fibronectin on lipogenesis were significantly attenuated by ATN161 in HepG2 cells. Conclusion Inhibition of fibronectin/integrin β signaling with ATN161 may block hepatic fibrotic signaling at the expense of increasing hepatic lipid accumulation through PPAR γ in mice fed with high fat diet during a short term. (Chin J Endocrinol Metab, 2016, 32: 773-780) Key words: Fibronectin; Integrin β; High fat diet; Nonalcoholic fatty liver disease; Peroxisome proliferator-activated receptor γ

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
随想完成签到 ,获得积分10
刚刚
刚刚
乳酸鸡完成签到,获得积分10
1秒前
王永明完成签到,获得积分10
9秒前
10秒前
李健应助麻花精采纳,获得30
12秒前
夏尔完成签到,获得积分10
12秒前
南辞完成签到 ,获得积分10
13秒前
ESLG发布了新的文献求助10
14秒前
在水一方应助秀丽嘉熙采纳,获得10
15秒前
生动的薯片完成签到,获得积分10
15秒前
15秒前
nnn完成签到,获得积分10
15秒前
dorothy完成签到,获得积分10
15秒前
Athwena应助Tonypig采纳,获得100
18秒前
ding应助烦恼大海采纳,获得10
21秒前
华仔应助一念春风采纳,获得10
22秒前
22秒前
CanadaPaoKing发布了新的文献求助10
22秒前
何时到达发布了新的文献求助60
23秒前
24秒前
Jonathan完成签到,获得积分10
24秒前
24秒前
饼应dundun完成签到,获得积分20
25秒前
mirror应助金金采纳,获得10
27秒前
兵王应助金金采纳,获得10
27秒前
Ava应助CanadaPaoKing采纳,获得10
27秒前
28秒前
杨123完成签到,获得积分10
28秒前
31秒前
文章快快来完成签到,获得积分10
31秒前
领导范儿应助无语的灵凡采纳,获得10
32秒前
小巧的昊强完成签到,获得积分10
34秒前
35秒前
霓霓发布了新的文献求助10
35秒前
36秒前
LY完成签到,获得积分10
39秒前
40秒前
40秒前
NexusExplorer应助你求我一下采纳,获得10
41秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Elgar Concise Encyclopedia of Space Law 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6943815
求助须知:如何正确求助?哪些是违规求助? 8629338
关于积分的说明 18304845
捐赠科研通 6378618
什么是DOI,文献DOI怎么找? 3079068
关于科研通互助平台的介绍 2119722
邀请新用户注册赠送积分活动 2056006